GEN Exclusives

More »

GEN News Highlights

More »
Jan 25, 2011

BD Extends Reagent Supply Contract with Abaxis

  • Abaxis and BD have inked a new 10-year agreement in which Abaxis will supply its Orbos Discrete Lyophilization Process to BD. The deal takes effect immediately and replaces a previous and expiring five-year agreement. Abaxis has been a supplier to BD since 1994. The new contract has an estimated value, based on current demand, of $30 million over the life of the contract.

    Abaxis uses the Orbos Discrete Lyophilization Process to produce dry reagents. The process involves flash-freezing a drop of liquid reagent to form a solid bead and then freeze-drying the bead to remove water. The Orbos beads are stable in dry form and dissolve rapidly in aqueous solutions.

    The Orbos process has applications in products where delivery of active ingredients in a stable, premetered format is desired. It allows the production of a precise amount of active chemical ingredient in the form of a soluble bead, according to Abaxis.

    Abaxis also licenses its Orbos process to bioMerieux, Cepheid, and GE Healthcare. In addition, it has a supply contract with Becton, Dickinson and Company for products using the Orbos process.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Patients Access to Experimental Medicines?

More »